EDGAR Filing Documents for 0001479290-21-000076

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001479290-21-000076

Filing Date

2021-03-11

Accepted

2021-03-11 17:11:59

Documents

Period of Report

2020-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	DEF 14A	rvncfy20proxystatementpre1.htm	DEF 14A	1341849
2		angus_russell1.jpg	GRAPHIC	56811
3		arankin_skills-201.jpg	GRAPHIC	45722
4		arussell_skills-121.jpg	GRAPHIC	67197
5		arussellsignature1.jpg	GRAPHIC	6734
6		aubreyrankin-photoxcopyx21.jpg	GRAPHIC	165076
7		carey_021.jpg	GRAPHIC	866025
8		chart-0526e658de784cf288a1a.jpg	GRAPHIC	13237
9		chart-0f17c541ba93489ba481a.jpg	GRAPHIC	14029
10		chart-5d503183a52b457cbc01a.jpg	GRAPHIC	12705
11		chart-840126e7a9994abc8521a.jpg	GRAPHIC	12174
12		chris_nolet1.jpg	GRAPHIC	23924
13		ckolaja_skills-191.jpg	GRAPHIC	49246
14		cnolet_skills-161.jpg	GRAPHIC	48680
15		jberaud_skills-181.jpg	GRAPHIC	52660
16		jgangolli_skills-131.jpg	GRAPHIC	74023
17		jill_beraud-e1565295726769.jpg	GRAPHIC	17581
18		julian_gangolli1.jpg	GRAPHIC	20006
19		mark_foley1.jpg	GRAPHIC	19277
20		marksigniture20191.jpg	GRAPHIC	120509
21		mfoley_skills-151.jpg	GRAPHIC	81800
22		olivia-copy1.jpg	GRAPHIC	492831
23		oware_skills-141.jpg	GRAPHIC	49372
24		philip_vickers1.jpg	GRAPHIC	36454
25		pvickers_skills-171.jpg	GRAPHIC	68433
26		revance_iconxbeautyxteal3.gif	GRAPHIC	11533
27		revance_iconxconnectedxteaa.gif	GRAPHIC	21945
28		revance_iconxdataxreadxouta.gif	GRAPHIC	13929
29		revance_iconxfinancexteal3.gif	GRAPHIC	17578
30		revance_iconxfindxteamxtea.gif	GRAPHIC	16910
31		revance_iconxmarketingxteab.gif	GRAPHIC	13192
32		revance_iconxmedicalxteal3.gif	GRAPHIC	9079
33		revance_iconxpartnershipxta.gif	GRAPHIC	15809
34		revance_iconxproductxpipelb.gif	GRAPHIC	10362
35		revance_iconxteamxteal3.gif	GRAPHIC	20013
36		revancetherapeuticsinc_v00.jpg	GRAPHIC	135397
37		revancetherapeuticsinc_v00a.jpg	GRAPHIC	136093
38		sage_audacityxnew1.jpg	GRAPHIC	633243
39		sage_empathyxnew1.jpg	GRAPHIC	1046068
40		sage_gritxnew1.jpg	GRAPHIC	672615
41		sage_speedxnew1.jpg	GRAPHIC	797654
42		tobyelectronicsignature2a0.jpg	GRAPHIC	96323
	Complete submission text file	0001479290-21-000076.txt		9177906

Mailing Address 7555 GATEWAY BLVD NEWARK CA 94560

Business Address 1222 DEMONBREUN STREET SUITE 1001 NASHVILLE TN 37203 510-742-3400

Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)